DD251208A5 - Immunologisches verfahren zur erkennung maligner zellen mit metadatischer zellaktivitaet - Google Patents

Immunologisches verfahren zur erkennung maligner zellen mit metadatischer zellaktivitaet Download PDF

Info

Publication number
DD251208A5
DD251208A5 DD84263171A DD26317184A DD251208A5 DD 251208 A5 DD251208 A5 DD 251208A5 DD 84263171 A DD84263171 A DD 84263171A DD 26317184 A DD26317184 A DD 26317184A DD 251208 A5 DD251208 A5 DD 251208A5
Authority
DD
German Democratic Republic
Prior art keywords
type
antibody
antigen
collagenase
cells
Prior art date
Application number
DD84263171A
Other languages
German (de)
English (en)
Inventor
Karl Tryggvason
Lance A Liotto
Original Assignee
Kk
����k�������@�Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kk, ����k�������@�Kk�� filed Critical Kk
Publication of DD251208A5 publication Critical patent/DD251208A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489Metalloendopeptidases (3.4.24)
    • C12N9/6491Matrix metalloproteases [MMP's], e.g. interstitial collagenase (3.4.24.7); Stromelysins (3.4.24.17; 3.2.1.22); Matrilysin (3.4.24.23)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486Metalloendopeptidases (3.4.24)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2474/00Immunochemical assays or immunoassays characterised by detection mode or means of detection
    • G01N2474/20Immunohistochemistry assay
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function
    • Y10S436/813Cancer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
DD84263171A 1983-05-19 1984-05-18 Immunologisches verfahren zur erkennung maligner zellen mit metadatischer zellaktivitaet DD251208A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/496,230 US4677058A (en) 1983-05-19 1983-05-19 Detecting malignant cells with monoclonal antibodies specific to type IV collagenase enzyme

Publications (1)

Publication Number Publication Date
DD251208A5 true DD251208A5 (de) 1987-11-04

Family

ID=23971775

Family Applications (1)

Application Number Title Priority Date Filing Date
DD84263171A DD251208A5 (de) 1983-05-19 1984-05-18 Immunologisches verfahren zur erkennung maligner zellen mit metadatischer zellaktivitaet

Country Status (26)

Country Link
US (1) US4677058A (it)
JP (1) JPS602187A (it)
AU (1) AU2808784A (it)
BE (1) BE899663A (it)
CA (1) CA1230052A (it)
CH (1) CH668838A5 (it)
DD (1) DD251208A5 (it)
DE (1) DE3418625A1 (it)
DK (1) DK243184A (it)
ES (1) ES8605904A1 (it)
FI (1) FI841897A (it)
FR (1) FR2546302B1 (it)
GB (1) GB2142030B (it)
HU (1) HU195004B (it)
IL (1) IL71802A0 (it)
IT (1) IT1175842B (it)
LU (1) LU85366A1 (it)
NL (1) NL8401616A (it)
NO (1) NO841993L (it)
NZ (1) NZ208108A (it)
PL (1) PL247745A1 (it)
PT (1) PT78610B (it)
RO (1) RO92427A (it)
SE (1) SE8402703L (it)
YU (1) YU86984A (it)
ZA (1) ZA843539B (it)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294172B1 (en) 1983-08-12 2001-09-25 Dade Behring Marburg Gmbh Monoclonal antibodies with specificity for membrane-associated antigens
US4859581A (en) * 1986-03-10 1989-08-22 Board Of Regents, The University Of Texas System Endoglycosidase assay
US4923818A (en) * 1987-09-04 1990-05-08 Washington University DNA clone of human type IV collagenase
GB2209526B (en) * 1987-09-04 1992-06-03 Univ Washington Dna clone of human type iv collagenase
US4876332A (en) * 1987-10-08 1989-10-24 Regents Of The Univeristy Of Minnesota Polypeptides with type IV collagen activity
US5280106A (en) * 1988-05-20 1994-01-18 Liotta Lance A Matrix metalloproteinase peptides: role in diagnosis and therapy
US5030555A (en) * 1988-09-12 1991-07-09 University Of Florida Membrane-strip reagent serodiagnostic apparatus and method
DE3909799A1 (de) * 1989-03-24 1990-09-27 Behringwerke Ag Monoklonale antikoerper (mak) gegen tumorassoziierte antigene, ihre herstellung und verwendung
US4992537A (en) * 1989-05-15 1991-02-12 Washington University cDNA encoding 92-kDA type IV collagenase
EP0495910B1 (en) * 1989-10-18 2001-09-26 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Production and use of human nm23-h2 protein and antibodies therefor
WO1991011714A1 (en) * 1990-01-26 1991-08-08 The United States Of America, Represented By The Secretary, United States Department Of Commerce A method for quantitatively measuring collagenase
WO1992020820A1 (en) * 1991-05-15 1992-11-26 Vanderbilt University Method to determine metastatic potential of tumor cells
US5324634A (en) * 1992-03-31 1994-06-28 The Research Foundation Of State University Of New York Diagnostic tests measuring gelatinase/inhibitor complexes for detection of aggressive and metastatic cancer
JP2673929B2 (ja) * 1993-04-12 1997-11-05 富士薬品工業株式会社 ヒト間質型コラゲナーゼと阻害剤との複合体の免疫学的定量法および臨床診断への応用
EP1789195B1 (en) * 2004-08-26 2010-10-27 Life Technologies Corporation Electrowetting dispensing devices and related methods

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE343949B (it) * 1966-06-02 1972-03-20 Pharmacia Ab
DE2363854C3 (de) * 1973-12-21 1980-01-03 Behringwerke Ag, 3550 Marburg Substrat zur Proteinasebestimmung sowie dessen Herstellung
US4201763A (en) * 1975-10-09 1980-05-06 Bio-Rad Laboratories, Inc. Solid phase immunofluorescent assay method
DE3239410A1 (de) * 1981-10-27 1983-05-19 Hybritech Inc., 92121 San Diego, Calif. Monoklonale antikoerper zu tumorassoziiertem antigen, zusammensetzungen, welche diese enthalten und deren anwendung zum tumornachweis
US4424278A (en) * 1981-11-16 1984-01-03 Research Corporation Cancer detection procedure using an acyl carrier protein
US4443367A (en) * 1982-04-08 1984-04-17 Monsanto Company Peptide and peptolide substrates for mammalian collagenase

Also Published As

Publication number Publication date
IL71802A0 (en) 1984-09-30
GB2142030B (en) 1987-02-04
FR2546302B1 (fr) 1988-03-04
AU2808784A (en) 1984-11-22
RO92427A (ro) 1987-09-30
CH668838A5 (de) 1989-01-31
US4677058A (en) 1987-06-30
FI841897A (fi) 1984-11-20
IT1175842B (it) 1987-07-15
JPS602187A (ja) 1985-01-08
FI841897A0 (fi) 1984-05-11
NL8401616A (nl) 1984-12-17
DE3418625A1 (de) 1984-11-22
LU85366A1 (fr) 1984-11-19
SE8402703L (sv) 1984-11-20
PL247745A1 (en) 1985-08-27
DK243184D0 (da) 1984-05-17
FR2546302A1 (fr) 1984-11-23
ES532597A0 (es) 1986-04-01
PT78610A (en) 1984-06-01
IT8420998A0 (it) 1984-05-18
DK243184A (da) 1984-11-20
HU195004B (en) 1988-03-28
HUT34261A (en) 1985-02-28
ZA843539B (en) 1985-07-31
NZ208108A (en) 1988-04-29
IT8420998A1 (it) 1985-11-18
GB2142030A (en) 1985-01-09
ES8605904A1 (es) 1986-04-01
BE899663A (fr) 1984-08-31
SE8402703D0 (sv) 1984-05-18
NO841993L (no) 1984-11-20
GB8411959D0 (en) 1984-06-13
PT78610B (en) 1986-07-15
CA1230052A (en) 1987-12-08
YU86984A (en) 1991-01-28

Similar Documents

Publication Publication Date Title
EP0158599B1 (de) Neue monoklonale Antikörper und Hybridoma-Zellen, Verfahren zu ihrer Herstellung und ihre Anwendungen
DE69117292T3 (de) Bestimmung von freiem und komplexiertem prostata-spezifischem antigen
DE68912403T2 (de) Monoklonaler Antikörper, spezifisch für eine in transformierten Zellen exprimierte Fibronectin-Sequenz, Hybridoma, das diesen Antikörper erzeugt und Verwendung dieses monoklonalen Antikörpers zur Diagnose von Tumoren.
DD251208A5 (de) Immunologisches verfahren zur erkennung maligner zellen mit metadatischer zellaktivitaet
EP0260610A2 (de) Monoklonale Antikörper gegen humanen Tumonekrosefaktor (TNF) und deren Verwendung
DE60017019T2 (de) Antikörper gegen Spaltprodukte von Vimentin
DE69132122T2 (de) Reinigung von cytokeratinfragmenten
EP0541645B1 (de) Verfahren zur reinigung von cytokeratin 20 und dessen verwendung zur erzeugung von antikörpern
DE68921374T2 (de) Monoklonaler Antikörper gegen menschliche Mangan-Superoxiddismutase, Verfahren zu dessen Herstellung, Testreagens, Kit und Testmethode unter Verwendung desselben, Verfahren zur Diagnose von menschlichem Eierstockkrebs und von Herzinfarkt.
DE3876124T2 (de) Immunoassay fuer thrombomodulin.
DE3485965T2 (de) Monoklonaler antikoerper mit spezifitaet gegen nur einen typ eines isozyms der schweren kette des menschlichen herzmyosins.
EP0955361A1 (de) Monoklonale Antikörper gegen tumorassoziierte Antigene, Verfahren zu ihrer Herstelung sowie ihre Verwendung
EP0339443A2 (de) Monoklonaler Antikörper zur selektiven immunologischen Bestimmung von intaktem Prokollagen Peptid (Typ III) und Prokollagen (Typ III) in Körperflüssigkeiten
DE69619226T2 (de) Monoklonaler antikörper gegen den komplex aus faktor xa und dem inhibitor für den gewebefaktor (xa. tfpi)
DE69322847T2 (de) Monoklonaler Antikörper gegen menschliches Ceruloplasmin
DE3686766T2 (de) Monoklonaler antikoerper gegen glutathion s-transferase und dessen verwendung zur diagnose von krebs.
DE3888604T2 (de) Monoklonale Antikörper gegen Antithrombinbindende Substanz und seine Verwendungen.
DE3743402C2 (de) Verfahren zur Krebsdiagnose beim Menschen
DE69129582T2 (de) Antikörper gegen menschlichen plasmin-alpha 2-plasmininhibitor-komplex, hybridoma und immunoassay
DE69005297T2 (de) Metastasenzugehörige kollagenolytische metalloproteinase.
DE3686599T2 (de) Verfahren zur bestimmung der leichten kette von myosin.
DE69800080T2 (de) Antikörper gegen das Prorenin Profragment, reninaktive Substanz die diese enthält und Prorenintest die diese verwendet
EP0195331A2 (de) Monoklonale Antikörper gegen atriale, natriurethische Peptide
EP1541676B1 (de) Gegen das Prothrombin-Fragment F1+2 gerichtete Antikörper, ihre Herstellung und Verwendung
DE68911574T2 (de) Reagenzsystem zur Bestimmung des Komplexes des menschlichen Plasminogenaktivator-Inhibitors und des menschlichen Gewebeplasminogenaktivators und Testsatz dafür.